Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Market / Stock-market-news/  Brokers seek Sebi probe of Ranbaxy trades before Sun Pharma deal
BackBack

Brokers seek Sebi probe of Ranbaxy trades before Sun Pharma deal

The president of Indian brokerage association plans to formally request Sebi to initiate investigation

Ranbaxy shares surged 24% in the three trading sessions leading up to the announcement on Monday that Sun Pharmaceutical had agreed to buy Ranbaxy for $3.2 billion. Photo: Pradeep Gaur/MintPremium
Ranbaxy shares surged 24% in the three trading sessions leading up to the announcement on Monday that Sun Pharmaceutical had agreed to buy Ranbaxy for $3.2 billion. Photo: Pradeep Gaur/Mint

Mumbai: The president of an Indian brokerage association is planning to formally request that India’s market regulator Securities and Exchange Board of india (Sebi) investigate trading in Ranbaxy Laboratories Ltd shares in the days leading up to its acquisition by Sun Pharmaceutical Industries Ltd.

Ranbaxy shares surged 24% in the three trading sessions leading up to the announcement on Monday that Sun Pharma had agreed to buy Ranbaxy for $3.2 billion.

“Because there was such kind of price movement before the deal was announced, we have decided to check with the regulator," Naresh Tejwani, president of the Association of National Exchanges Members of India (ANMI) said on Wednesday.

“We will write to them by the end of the day to investigate into the matter."

A Ranbaxy spokesman declined to comment.

A spokesman for Sebi also declined to comment.

Sun Pharma did not immediately respond to requests for comment.

On Wednesday, shares in Sun Pharma gained as much as 8.1%, adding to their 2.9% rise on Monday, as brokers upgrade the stock after the company agreed to buy Ranbaxy for $3.2 billion. Shares of Ranbaxy, too, rose as much as 6.23%.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 09 Apr 2014, 01:59 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App